Cargando…

Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery

Optical coherence tomography (OCT) has potential as a modality for in vivo imaging of non-melanoma skin cancer (NMSC). By allowing identification of sub-surface margins of NMSC lesions, the use of OCT could improve the rate of complete excision and reduce the average number of stages during Mohs mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Pomerantz, Rebecca, Zell, Deborah, McKenzie, Gordon, Siegel, Daniel M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219453/
https://www.ncbi.nlm.nih.gov/pubmed/22110434
http://dx.doi.org/10.1159/000333000
_version_ 1782216842595532800
author Pomerantz, Rebecca
Zell, Deborah
McKenzie, Gordon
Siegel, Daniel M.
author_facet Pomerantz, Rebecca
Zell, Deborah
McKenzie, Gordon
Siegel, Daniel M.
author_sort Pomerantz, Rebecca
collection PubMed
description Optical coherence tomography (OCT) has potential as a modality for in vivo imaging of non-melanoma skin cancer (NMSC). By allowing identification of sub-surface margins of NMSC lesions, the use of OCT could improve the rate of complete excision and reduce the average number of stages during Mohs micrographic surgery (MMS). The objective of this study was to use OCT to delineate the apparent sub-surface margins of NMSC lesions prior to their excision by MMS. Lesions were scanned with reference to a physical marker on the skin, and the apparent margins were then identified from the OCT images and marked on the skin. Photographs of these margins and the Mohs defect were correlated and compared. OCT appears capable of visualizing the transition from lesional to normal tissue. In this case study, margins marked by use of the OCT system before surgery exhibit excellent correlation with the MMS defect. OCT offers the promise of better outcomes by enabling accurate margin mapping of NMSC in advance of MMS. Priorities now are to demonstrate this capability in a larger study, and to understand clearly indications and contraindications for use.
format Online
Article
Text
id pubmed-3219453
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-32194532011-11-22 Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery Pomerantz, Rebecca Zell, Deborah McKenzie, Gordon Siegel, Daniel M. Case Rep Dermatol Published: September 2011 Optical coherence tomography (OCT) has potential as a modality for in vivo imaging of non-melanoma skin cancer (NMSC). By allowing identification of sub-surface margins of NMSC lesions, the use of OCT could improve the rate of complete excision and reduce the average number of stages during Mohs micrographic surgery (MMS). The objective of this study was to use OCT to delineate the apparent sub-surface margins of NMSC lesions prior to their excision by MMS. Lesions were scanned with reference to a physical marker on the skin, and the apparent margins were then identified from the OCT images and marked on the skin. Photographs of these margins and the Mohs defect were correlated and compared. OCT appears capable of visualizing the transition from lesional to normal tissue. In this case study, margins marked by use of the OCT system before surgery exhibit excellent correlation with the MMS defect. OCT offers the promise of better outcomes by enabling accurate margin mapping of NMSC in advance of MMS. Priorities now are to demonstrate this capability in a larger study, and to understand clearly indications and contraindications for use. S. Karger AG 2011-09-30 /pmc/articles/PMC3219453/ /pubmed/22110434 http://dx.doi.org/10.1159/000333000 Text en Copyright © 2011 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: September 2011
Pomerantz, Rebecca
Zell, Deborah
McKenzie, Gordon
Siegel, Daniel M.
Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery
title Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery
title_full Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery
title_fullStr Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery
title_full_unstemmed Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery
title_short Optical Coherence Tomography Used as a Modality to Delineate Basal Cell Carcinoma prior to Mohs Micrographic Surgery
title_sort optical coherence tomography used as a modality to delineate basal cell carcinoma prior to mohs micrographic surgery
topic Published: September 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219453/
https://www.ncbi.nlm.nih.gov/pubmed/22110434
http://dx.doi.org/10.1159/000333000
work_keys_str_mv AT pomerantzrebecca opticalcoherencetomographyusedasamodalitytodelineatebasalcellcarcinomapriortomohsmicrographicsurgery
AT zelldeborah opticalcoherencetomographyusedasamodalitytodelineatebasalcellcarcinomapriortomohsmicrographicsurgery
AT mckenziegordon opticalcoherencetomographyusedasamodalitytodelineatebasalcellcarcinomapriortomohsmicrographicsurgery
AT siegeldanielm opticalcoherencetomographyusedasamodalitytodelineatebasalcellcarcinomapriortomohsmicrographicsurgery